N99-02: Melphalan and Buthionine Sulfoximine

NCT00005835 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: buthionine sulfoximine
DRUG: melphalan
PROCEDURE: Peripheral blood stem cell infusion
OTHER: Filgrastim

Sponsor

New Approaches to Neuroblastoma Therapy Consortium

Collaborators

[object Object]